4-Chlorothiazole-5-carboxylic acid

Catalog No.: 
ACSNLZ028
CAS No.: 
444909-59-5
Molecular Formula: 
C4H2ClNO2S
Molecular Weight: 
163.59
4-Chlorothiazole-5-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg98%$70.00In stockInquiry
25mg98%$133.00In stockInquiry
50mg98%$177.00In stockInquiry
100mg98%$261.00In stockInquiry
250mg98%$322.00In stockInquiry
1g98%$756.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chlorothiazole-5-carboxylic acid
IUPAC Name4-chlorothiazole-5-carboxylic acid
MDL No.MFCD09837290
Molecular FormulaC4H2ClNO2S
Molecular Weight163.59
SMILESO=C(C1=C(Cl)N=CS1)O
InChI KeyPIORVFYHSPLLLG-UHFFFAOYSA-N
Synonym4-Chlorothiazole-5-carboxylic acid;4-chloro-1,3-thiazole-5-carboxylic acid;5-Thiazolecarboxylic acid, 4-chloro-;4-Chloro-5-thiazolecarboxylic acid
CAS No.444909-59-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSNLZ028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLMKX431 route compound structure diagram
    ACLMKX431104146-17-0In Stock
  2. Then
  3. ACSNLZ028 route product structure diagram
    ACSNLZ028444909-59-5In Stock
Inquiry

2. ACSNLZ028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSNLZ028 route product structure diagram
    ACSNLZ028444909-59-5In Stock
Inquiry

3. ACSNLZ028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSNLZ028 route product structure diagram
    ACSNLZ028444909-59-5In Stock
Inquiry

Comments (0)